Diagnosing Streptococcal Pharyngitis with Centor Criteria

Clinical Features and Scoring

• The Centor criteria consist of four clinical features: fever by history, tonsillar exudates, tender anterior cervical adenopathy, and absence of cough, which help identify patients with higher likelihood of group A streptococcal pharyngitis 1, 2
• The four components of the Centor clinical scoring system are: fever by history, tonsillar exudates, tender anterior cervical adenopathy, and absence of cough 1, 2

Diagnostic Approach and Interpretation

• Patients with fewer than 3 Centor criteria do not need to be tested for group A streptococcus as they have a low probability of streptococcal pharyngitis 1, 3
• In patients with high likelihood of streptococcal infections (3-4 Centor criteria), physicians should consider using rapid antigen tests (RATs) 2, 4, 3
• If RAT is performed, throat culture is not necessary after a negative RAT for the diagnosis of group A streptococci in both children and adults 4, 3

Treatment Considerations

• Antibiotics should not be used in patients with less severe presentation (0-2 Centor criteria) 3, 5
• For patients with 3-4 Centor criteria, modest benefits of antibiotics should be weighed against side effects, impact on microbiota, increased antibiotic resistance, medicalization, and costs 3, 5
• If antibiotics are indicated based on Centor criteria and confirmatory testing, penicillin V for 10 days is the recommended first-line treatment 3, 5

Limitations and Considerations

• The Centor criteria have a low positive predictive value for determining the presence of group A streptococcal infection 1
• The utility of Centor criteria appears lower in children than in adults because of different clinical presentation of sore throat in the first years of life 4

Diagnosing Streptococcal Pharyngitis with the Centor Score

Components and Risk Stratification

• The Centor score consists of four clinical features, including fever by history, tonsillar exudates, tender anterior cervical adenopathy, and absence of cough, with one point assigned for each, as recommended by the Infectious Diseases Society of America 6
• A score of 0 indicates a 2.5% risk of GAS infection, while a score of 1 indicates a 5-10% risk, a score of 2 indicates an 11-17% risk, a score of 3 indicates a 28-35% risk, and a score of 4 indicates a 51-53% risk of GAS infection, according to the American Academy of Pediatrics 6, 7
• The modified Centor score includes age as an additional criterion, with 1 point added for ages 3-14, 0 points for ages 15-44, and 1 point subtracted for ages ≥45, as suggested by the American College of Physicians 6, 7

Diagnostic Accuracy and Testing Recommendations

• Improper swabbing technique can reduce test accuracy, and both posterior pharyngeal wall and tonsils should be swabbed, as recommended by the Centers for Disease Control and Prevention 7, 8
• The accuracy of RADTs increases when performed in patients with higher Centor scores, with high specificity (≥95%) but variable sensitivity (80-90%) compared to throat culture, according to the Infectious Diseases Society of America 8

Centor Criteria for the Management of Group A Streptococcal Pharyngitis

Overview of the Scoring System

• The Centor criteria comprise four clinical features—history of fever, tonsillar exudate, tender anterior cervical adenopathy, and absence of cough—that together stratify the likelihood of Group A Streptococcus infection and direct testing and antibiotic decisions. 9

Individual Criterion Weight

• A reported fever (temperature ≥ 38.9 °C) contributes 1 point to the Centor score. 10

Low‑Risk Patients (Score 0–2)

• For patients with a Centor score of 0–2, routine streptococcal testing and antibiotic therapy are not recommended. [9][11]
• Symptomatic relief should be provided with non‑steroidal anti‑inflammatory drugs (e.g., ibuprofen) or acetaminophen. [11][10]
• Rapid antigen testing (RAT) is not routinely required in this low‑risk group. [12][13]
• The majority of low‑score presentations are viral and self‑limiting. 11

High‑Risk Patients (Score 3–4)

• Patients scoring 3–4 should undergo a rapid antigen test to confirm infection before antibiotics are prescribed. [9][12]11

Management When RAT Is Positive

• Penicillin V for 10 days (standard adult dosing) is the first‑line therapy. [11][10]
• Amoxicillin (≈ 50 mg/kg once daily, max 1 g) for 10 days is an acceptable alternative. 10
• For non‑anaphylactic penicillin allergy, a first‑generation cephalosporin may be used. 11
• For anaphylactic penicillin allergy, prescribe clindamycin or clarithromycin. 11

Management When RAT Is Negative

• Adults: No confirmatory throat culture is needed; a negative RAT is sufficient to exclude streptococcal infection. [12][11]
• Children and adolescents: A backup throat culture is required because RAT sensitivity ranges from 80 % to 90 %. [12][11]
• While awaiting culture results, provide only symptomatic treatment. 11

Considerations Regarding Antibiotic Use

• The clinical benefit of antibiotics in patients with scores 3–4 is modest and must be weighed against adverse effects, with a number needed to treat (NNT) of 6 to prevent symptoms at 3 days and 21 at one week. 10
• Antibiotic therapy can disrupt intestinal microbiota. 10
• Use of antibiotics contributes to increased bacterial resistance. 9
• Unnecessary antibiotic prescribing leads to medical over‑use. 10
• Preventing suppurative complications (e.g., peritonsillar abscess, acute otitis media, cervical lymphadenitis) is not a specific indication for antibiotics, as such complications are rare. [9][11]10

Pediatric Limitations

• The predictive utility of the Centor criteria is lower in children than in adults, reflecting differing clinical presentations of pharyngitis in younger ages. [9][11]

Household Contact Management

• Up to one‑third of household members may be asymptomatic carriers, and prophylactic antibiotic treatment of contacts does not reduce subsequent infection rates. 10

Validation Population

• The Centor criteria were primarily validated in adult populations; caution is advised when applying them to pediatric patients. [9][11]

Comparison of Centor and Modified McIsaac Scores for Group A Streptococcal Pharyngitis

Score Definitions

• The McIsaac score is a modification of the original Centor score that adds an age‑adjustment variable, extending its applicability to children and adolescents, whereas the Centor score contains only the four core clinical criteria and is intended for adults. 14
• The original Centor score assigns one point each for tonsillar exudate, tender anterior cervical lymphadenopathy, absence of cough, and a history of fever, yielding a total possible score of 0–4; it was validated exclusively in adult populations. 14
• The Modified McIsaac score incorporates the same four criteria plus an age component: +1 point for patients aged 3–14 years, 0 points for ages 15–44 years, and –1 point for ages ≥45 years, resulting in a possible range of –1 to 5. 14

Validation Evidence

• A Canadian validation study evaluated the McIsaac score in approximately 600 participants (both adults and children aged 3–15 years), confirming its performance across age groups. 14

Risk Stratification

• Centor score risk estimates (adults):

  • Score 0 → ~2.5 % probability of Group A Streptococcus (GAS) infection.
  • Score 1 → 5–10 % probability.
  • Score 2 → 11–17 % probability.
  • Score 3 → 28–35 % probability.
  • Score 4 → 51–53 % probability. 14

• McIsaac score risk estimates (patients ≥ 3 years): overall GAS positivity ≈ 27 %; by score:

  • Score –1/0 → 8 % positivity.
  • Score 1 → 14 % positivity.
  • Score 2 → 23 % positivity.
  • Score 3 → 37 % positivity.
  • Score 4 → 55 % positivity. 14

Clinical Application

• In primary‑care settings, the Centor score should be applied to adult patients (≥ 15 years) presenting with sore throat to estimate GAS risk and guide testing or treatment decisions. 14
• The McIsaac score is recommended when evaluating children and adolescents (3–14 years) or when a single scoring system is desired for patients of all ages, because it accounts for age‑related differences in presentation. 14
• The two scores are not interchangeable; the age adjustment in the McIsaac system changes both the total possible score range and the interpretation of individual scores, so direct numerical comparison between the systems is inappropriate. 14

Modified McIsaac (Centor) Score for Group A Streptococcal Pharyngitis and Tonsillitis

Score Overview

• The modified McIsaac score was created for acute pharyngitis and is equally applicable to acute tonsillitis because both conditions represent the same clinical spectrum of Group A Streptococcus infection. 15

Core Criteria

• “Tonsillar swelling or exudate” is one of the five core criteria, ensuring the score’s relevance to tonsillitis presentations. 15

Score Components and Age Adjustment

• Five elements are scored (each +1 point unless otherwise noted):
  
  • Body temperature ≥ 38 °C.
  • Absence of cough (original Centor element, not cited here).
  • Tender anterior cervical adenopathy (original Centor element, not cited here).
  • Tonsillar swelling/exudate.
  • Age: 3‑14 years = +1; 15‑44 years = 0; ≥ 45 years = ‑1.
  • These components were defined and validated in the original study. 15
• Incorporating age‑related risk adjustment extends the score’s validity to children ≥ 3 years, reflecting the known variation in GAS risk by age group. 15

Clinical Decision Algorithm

• Score ‑1, 0, or 1: No antibiotics or microbiologic testing; provide symptomatic care only. 15
• Score 2 or 3: Perform a rapid antigen detection test (RADT) or throat culture; prescribe antibiotics only if the test is positive. [15][16]
• Score 4: Either start empiric antibiotics immediately or obtain confirmatory testing, because the probability of a true GAS infection is approximately 55 %. 15

Caveats When Viral Features Are Present

• The presence of viral signs (e.g., conjunctivitis, coryza, cough, diarrhea, hoarseness, oral ulcers, or viral exanthem) markedly lowers the likelihood of GAS infection, even with higher scores, and may obviate the need for testing. [16][17]

Testing Technique and Follow‑up

• In adults with a negative RADT, routine backup throat culture is generally unnecessary given the low incidence of disease and low risk of rheumatic fever. [16][17]

All facts are derived from peer‑reviewed sources and reflect the current evidence base for the modified McIsaac scoring system.